New drug duo tested against advanced cancers
Disease control
Completed
This early-phase study tested a new combination of two drugs, AK127 and AK104, in 67 people with advanced or metastatic solid tumours that had stopped responding to other treatments. The main goal was to check safety and find the right dose, while also looking at whether the tumo…
Phase: EARLY_PHASE1 • Sponsor: Akesobio Australia Pty Ltd • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC